University of Bologna - Department of Medical and Surgical Sciences Trials

University of Bologna - Department of Medical and Surgical Sciences	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Viale, Pierluigi

MANTICO 2, NCT05321394: Non-inferiority Trial on Treatments in Early COVID-19

Completed

536

Europe

Sotrovimab, Tixagevimab Cilgavimab, Nirmatrelvir Ritonavir

Azienda Ospedaliera Universitaria Integrata Verona, Agenzia Italiana del Farmaco, Azienda Sanitaria-Universitaria Integrata di Udine

COVID-19

10/23

REPAVID-22, NCT05254990 / 2021-006951-32: Reparixin add-on Therapy to Std Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia

Terminated

409

Europe, US, RoW

Reparixin, Repertaxin L-lysine salt, Placebo, Matched placebo

Dompé Farmaceutici S.p.A

Infectious Pneumonia, Severe COVID-19

09/24

PROTECT, NCT04363827 / 2020-001501-24: Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19)

Active, not recruiting

2300

Europe

Hydroxychloroquine

Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori, University of Bologna

COVID19, Hydroxychloroquine, Prophylaxis, Treatment, SARS-CoV-2

06/21

09/21

NCT06793111: Visceral Leishmaniasis in Emilia-Romagna (Leishmania-2019)

Recruiting

N/A

300

Europe

IRCCS Azienda Ospedaliero-Universitaria di Bologna, AUSL Romagna Rimini, Ospedale Bufalini di Cesena, Italy, Morgagni Pierantoni Hospital, Ospedale "Santa Maria delle Croci" di Ravenna - AUSL Romagna

Leishmaniasis, Visceral

05/25

12/25

IRENE, NCT03339063: The Italian REgistry of Pulmonary Non-tuberculous mycobactEria

Recruiting

N/A

500

Europe

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Niguarda Hospital, Azienda Ospedaliera San Gerardo di Monza, ASST Fatebenefratelli Sacco, Fondazione IRCCS Policlinico San Matteo di Pavia, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, University of Turin, Italy, A.O.U. Città della Salute e della Scienza - Molinette Hospital, Azienda Unità Locale Socio Sanitaria n.9 Treviso, Ospedale Maggiore Di Trieste, Azienda Ospedaliero-Universitaria di Modena, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Università degli Studi di Ferrara, IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy, Azienda Ospedaliero, Universitaria Pisana, Azienda Ospedaliero-Universitaria Careggi, Ospedale San Jacopo, Pistoia, Italy, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Azienda Policlinico Umberto I, Istituto Nazionale per le Malattie Infettive Spallanzani, Roma, Policlinico Universitario, Catania, Azienda Ospedaliera Universitaria Policlinico "G. Martino", Azienda Ospedaliera Cosenza, Azienda Ospedaliero Universitaria di Sassari

Nontuberculous Mycobacteria

12/22

RETRACE, NCT04170309: Collection of Data of Ceftobiprole Treated Patients: Comparison of Patients With and Without Certain Diseases

Completed

N/A

428

Europe

Ceftobiprole medocaril

Advanz Pharma, AMS Advanced Medical Services GmbH, APCER Life Sciences

Renal Insufficiency, Hepatic Insufficiency, Immunosuppression

06/23



	Diseases Companies Products Productz Mechanisms of Action Sites